About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 278405, 13 pages
http://dx.doi.org/10.1155/2013/278405
Research Article

Vitexicarpin Acts as a Novel Angiogenesis Inhibitor and Its Target Network

1MOE Key Laboratory of Bioinformatics and Bioinformatics Division, TNLIST, Department of Automation, Tsinghua University, Beijing 100084, China
2Joint Computational Center of Drug Discovery, Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin 300457, China

Received 22 October 2012; Accepted 20 November 2012

Academic Editor: Weidong Zhang

Copyright © 2013 Bo Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bo Zhang, Lu Liu, Shiwen Zhao, Xu Wang, Liyang Liu, and Shao Li, “Vitexicarpin Acts as a Novel Angiogenesis Inhibitor and Its Target Network,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 278405, 13 pages, 2013. doi:10.1155/2013/278405